While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Eli Lilly’s big-selling insulin ... in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into the biosimilar diabetes market, and has been persuaded ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Sliding scale insulin therapy involves following a chart of insulin dosages. A doctor will help a person with diabetes create this chart based on factors like how their body responds to insulin ...

Biosimilar insulin is also on its way, which could further erode potential sales. By comparison, a new product in Lilly’s diabetes portfolio ... pre-filled insulin pens and vials.

2025 — People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

When everything works correctly, the body will produce insulin to move glucose out of the blood and into the cells to rebalance the increased glucose levels. However, in someone with diabetes ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...